NDC Code(s) : 68001-266-28, 68001-266-30, 68001-266-29, 68001-266-31
Packager : BluePoint Laboratories
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
FluorouracilFluorouracil INJECTION, SOLUTION | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
LABELER - BluePoint Laboratories(985523874) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
Intas Pharmaceuticals Ltd | 725927649 | MANUFACTURE(68001-266), ANALYSIS(68001-266) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
Intas Pharmaceuticals Ltd | 915837971 | MANUFACTURE(68001-266), ANALYSIS(68001-266) |
PRINCIPAL DISPLAY PANEL
Fluorouracil Injection, USP
500 mg/10 mL (50 mg/mL) Vial Label
NDC 68001-266-28

PRINCIPAL DISPLAY PANEL
Fluorouracil Injection, USP
500 mg/10 mL (50 mg/mL) Vial Label
NDC 68001-266-28

PRINCIPAL DISPLAY PANEL
Fluorouracil Injection, USP
500 mg/10 mL (50 mg/mL) Carton Label
NDC 68001-266-30

PRINCIPAL DISPLAY PANEL
Fluorouracil Injection, USP
500 mg/10 mL (50 mg/mL) Carton Label
NDC 68001-266-30

PRINCIPAL DISPLAY PANEL
Fluorouracil Injection, USP
1 g/20 mL (50 mg/mL) Vial Label
NDC 68001-266-29

PRINCIPAL DISPLAY PANEL
Fluorouracil Injection, USP
1 g/20 mL (50 mg/mL) Vial Label
NDC 68001-266-29

PRINCIPAL DISPLAY PANEL
Fluorouracil Injection, USP
1 g/20 mL (50 mg/mL) Carton Label
NDC 68001-266-31

PRINCIPAL DISPLAY PANEL
Fluorouracil Injection, USP
1 g/20 mL (50 mg/mL) Carton Label
NDC 68001-266-31
